The Measles & Rubella Partnership (M&RP) is led by the American Red Cross, the Bill & Melinda Gates Foundation, Gavi the Vaccine Alliance, the United Nations Foundation, the U.S. Centers for Disease Control and Prevention, UNICEF and the World Health Organization.
The M&RP aims to achieve a world without measles and rubella by supporting countries to raise coverage of measles, rubella and other vaccines; fund, plan, implement and monitor quality supplementary campaigns; investigate outbreaks and provide technical and financial support for effective outbreak response, propose and participate in solutions to strengthen immunization delivery; and support a global laboratory network for measles and rubella.
Since 2001, the Partnership has supported 88 countries to deliver more than 3.86 billion doses of measles vaccine, helped to raise measles vaccination coverage to 83% globally, and reduced measles deaths by 82%. To date, the partnership has invested more than US $1.2 billion in measles and rubella control activities.
In 2022, the Measles & Rubella Partnership supported vaccination campaigns in 44 countries that reached more than 115 million children with bundled vaccines, operational costs or technical assistance.
Key supporters of the Measles & Rubella Partnership include countries and governments affected by measles, rubella and congenital rubella syndrome;
The Measles & Rubella Partnership is also grateful to its many individual private donors and supporters. Together we move faster.
Updated on January 10, 2023
Prelude Version 2.3.2